Gregory M. Mayhew

1.4k total citations
19 papers, 894 citations indexed

About

Gregory M. Mayhew is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Gregory M. Mayhew has authored 19 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Neurology. Recurrent topics in Gregory M. Mayhew's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Fibroblast Growth Factor Research (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Gregory M. Mayhew is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Fibroblast Growth Factor Research (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Gregory M. Mayhew collaborates with scholars based in United States, Netherlands and Germany. Gregory M. Mayhew's co-authors include Jeffery M. Vance, Eden R. Martin, William K. Scott, Yi‐Ju Li, Joelle M. van der Walt, Gaofeng Wang, Stephan Züchner, Mark Stacy, Dana B. Hancock and B.L. Scott and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Gregory M. Mayhew

17 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory M. Mayhew United States	8	482	287	196	145	133	19	894
Zhitao Han China	15	425 0.9×	245 0.9×	48 0.2×	139 1.0×	84 0.6×	30	822
Núria Llecha Spain	13	561 1.2×	111 0.4×	117 0.6×	191 1.3×	118 0.9×	15	888
Bong-Seon Kim South Korea	17	407 0.8×	102 0.4×	45 0.2×	77 0.5×	200 1.5×	28	754
Nedret Altıok Sweden	15	525 1.1×	172 0.6×	39 0.2×	200 1.4×	155 1.2×	22	853
Meltem Müftüoğlu United States	21	1.2k 2.4×	220 0.8×	135 0.7×	128 0.9×	139 1.0×	34	1.4k
Huan Xiong China	11	448 0.9×	319 1.1×	141 0.7×	140 1.0×	39 0.3×	15	1.1k
J.P. Julien Canada	15	265 0.5×	138 0.5×	212 1.1×	168 1.2×	222 1.7×	35	902
Hajime Abe Japan	15	264 0.5×	126 0.4×	31 0.2×	62 0.4×	77 0.6×	50	707

Countries citing papers authored by Gregory M. Mayhew

Since Specialization

Citations

This map shows the geographic impact of Gregory M. Mayhew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Mayhew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Mayhew more than expected).

Fields of papers citing papers by Gregory M. Mayhew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Mayhew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Mayhew. The network helps show where Gregory M. Mayhew may publish in the future.

Co-authorship network of co-authors of Gregory M. Mayhew

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory M. Mayhew. A scholar is included among the top collaborators of Gregory M. Mayhew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory M. Mayhew. Gregory M. Mayhew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Eisner, Joel R., Yoichiro Shibata, Gregory M. Mayhew, et al.. (2024). Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 30(23). 5374–5384. 2 indexed citations

Wenric, Stéphane, James M. Davison, John Guittar, et al.. (2024). Abstract 2542: Real-world validation of the PurIST classifier demonstrates enhanced therapy selection for pancreatic ductal adenocarcinoma (PDAC) patients. Cancer Research. 84(6_Supplement). 2542–2542.

Eisner, Joel R., Gregory M. Mayhew, James M. Davison, et al.. (2023). Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study. Clinical Cancer Research. 29(16). 3203–3213.

Eisner, Joel R., Gregory M. Mayhew, Yoichiro Shibata, et al.. (2022). Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer. Cancer Research Communications. 2(8). 894–903. 1 indexed citations

Mayhew, Gregory M., Joshua M. Uronis, D. Neil Hayes, & José P. Zevallos. (2022). Mesenchymal gene expression subtyping analysis for early-stage human papillomavirus-negative head and neck squamous cell carcinoma reveals prognostic and predictive applications. Frontiers in Oncology. 12. 954037–954037. 2 indexed citations

Wenric, Stéphane, James M. Davison, Gregory M. Mayhew, et al.. (2022). Abstract A002: Purity Independent Subtyping of Tumor (PurIST): Real-world data validation of a pancreatic ductal adenocarcinoma (PDAC) gene expression classifier and its prognostic implications. Cancer Research. 82(22_Supplement). A002–A002. 2 indexed citations

Rose, Tracy L., William H. Weir, Gregory M. Mayhew, et al.. (2021). Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. British Journal of Cancer. 125(9). 1251–1260. 108 indexed citations

Kim, William Y., Tracy L. Rose, Florian Roghmann, et al.. (2020). Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data.. Journal of Clinical Oncology. 38(6_suppl). 493–493. 4 indexed citations

Rose, Tracy L., Michele C. Hayward, Ashley H. Salazar, et al.. (2019). Fibroblast growth factor receptor status and response to immune checkpoint inhibition in metastatic urothelial cancer.. Journal of Clinical Oncology. 37(7_suppl). 458–458. 5 indexed citations

10.

Faruki, Hawazin, Gregory M. Mayhew, Jonathan S. Serody, et al.. (2017). Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape. Journal of Thoracic Oncology. 12(6). 943–953. 118 indexed citations

11.

Faruki, Hawazin, Gregory M. Mayhew, Cheng Fan, et al.. (2015). Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets. Archives of Pathology & Laboratory Medicine. 140(6). 536–542. 4 indexed citations

12.

Mayhew, Gregory M., et al.. (2013). Space–time clustering and the permutation moments of quadratic forms. Stat. 2(1). 292–302. 5 indexed citations

13.

Gao, Xiaoyi, Eden R. Martin, Yutao Liu, et al.. (2009). Genome-wide Linkage Screen in Familial Parkinson Disease Identifies Loci on Chromosomes 3 and 18. The American Journal of Human Genetics. 84(4). 499–504. 8 indexed citations

14.

Gao, Xiaoyi, William K. Scott, Gregory M. Mayhew, et al.. (2008). Gene‐Gene Interaction Between FGF20 and MAOB in Parkinson Disease. Annals of Human Genetics. 72(2). 157–162. 19 indexed citations

15.

Wang, Gaofeng, Joelle M. van der Walt, Gregory M. Mayhew, et al.. (2008). Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-Synuclein. The American Journal of Human Genetics. 82(2). 283–289. 360 indexed citations

16.

Hancock, Dana B., Eden R. Martin, Gregory M. Mayhew, et al.. (2008). Pesticide exposure and risk of Parkinson's disease: A family-based case-control study. BMC Neurology. 8(1). 6–6. 215 indexed citations

17.

Li, Yi‐Ju, et al.. (2007). Investigation of the PARK10 Gene in Parkinson Disease. Annals of Human Genetics. 71(5). 639–647. 13 indexed citations

18.

Kang, Sun Jung, William K. Scott, Yi‐Ju Li, et al.. (2006). Family‐based case–control study of MAOA and MAOB polymorphisms in Parkinson disease. Movement Disorders. 21(12). 2175–2180. 27 indexed citations

19.

Vance, Jeffery M., et al.. (2006). P1–361: Mapping genes affecting age–at–onset of Alzheimer's disease in the chromosome 8. Alzheimer s & Dementia. 2(3S_Part_7). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhitao Han Breakdown of academic impact, for papers by Núria Llecha Breakdown of academic impact, for papers by Bong-Seon Kim Breakdown of academic impact, for papers by Nedret Altıok Breakdown of academic impact, for papers by Meltem Müftüoğlu Breakdown of academic impact, for papers by Huan Xiong Breakdown of academic impact, for papers by J.P. Julien Breakdown of academic impact, for papers by Hajime Abe